Long-term follow-up of patients with culture-confirmed Lyme disease.

Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79

Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here? Qual Life Res (2013) 1.67

Chronic Lyme disease: a review. Infect Dis Clin North Am (2008) 1.46

Identification of novel activity against Borrelia burgdorferi persisters using an FDA approved drug library. Emerg Microbes Infect (2014) 1.43

Diagnostic challenges of early Lyme disease: lessons from a community case series. BMC Infect Dis (2009) 1.23

A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99

Variable VlsE is critical for host reinfection by the Lyme disease spirochete. PLoS One (2013) 0.96

The antibiotics doxycycline and minocycline inhibit the inflammatory responses to the Lyme disease spirochete Borrelia burgdorferi. J Infect Dis (2009) 0.95

Lyme neuroborreliosis-epidemiology, diagnosis and management. Nat Rev Neurol (2015) 0.91

Critical analysis of treatment trials of rhesus macaques infected with Borrelia burgdorferi reveals important flaws in experimental design. Vector Borne Zoonotic Dis (2012) 0.89

Detection of Borrelia burgdorferi nucleic acids after antibiotic treatment does not confirm viability. J Clin Microbiol (2012) 0.87

Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans. PLoS One (2011) 0.86

Generalizability in two clinical trials of Lyme disease. Epidemiol Perspect Innov (2006) 0.85

Lyme borreliosis reinfection: might it be explained by a gender difference in immune response? Immunology (2006) 0.84

Suppression of Long-Lived Humoral Immunity Following Borrelia burgdorferi Infection. PLoS Pathog (2015) 0.83

Evidence for strain-specific immunity in patients treated for early lyme disease. Infect Immun (2014) 0.82

Chronic Lyme disease. Infect Dis Clin North Am (2015) 0.82

Long-term Assessment of Post-Treatment Symptoms in Patients With Culture-Confirmed Early Lyme Disease. Clin Infect Dis (2015) 0.81

Long-term Follow-up of Patients With Lyme Disease: Longitudinal Analysis of Clinical and Quality-of-life Measures. Clin Infect Dis (2016) 0.80

Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings. PLoS One (2015) 0.78

CD4+ T cells promote antibody production but not sustained affinity maturation during Borrelia burgdorferi infection. Infect Immun (2014) 0.78

Longitudinal Transcriptome Analysis Reveals a Sustained Differential Gene Expression Signature in Patients Treated for Acute Lyme Disease. MBio (2016) 0.78

Lyme disease: Is it or is it not? Can J Infect Dis Med Microbiol (2005) 0.77

Central Nervous System Lyme Disease. Curr Infect Dis Rep (2004) 0.77

Editorial commentary: life after Lyme disease. Clin Infect Dis (2015) 0.77

Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi. PLoS One (2015) 0.76

Association between human leukocyte antigen class II alleles and genotype of Borrelia burgdorferi in patients with early lyme disease. J Infect Dis (2005) 0.76

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study. Clin Vaccine Immunol (2016) 0.75

Bill C-442: Shining the limelight on the Lyme-like? Can J Infect Dis Med Microbiol (2014) 0.75

Diet-Induced Obesity Does Not Alter Tigecycline Treatment Efficacy in Murine Lyme Disease. Front Microbiol (2017) 0.75

Rapid decline of OspC borreliacidal antibodies following treatment of patients with early Lyme disease. Clin Vaccine Immunol (2011) 0.75

The HUMTICK study: protocol for a prospective cohort study on post-treatment Lyme disease syndrome and the disease and cost burden of Lyme borreliosis in Belgium. Arch Public Health (2017) 0.75

The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis (2006) 13.01

A critical appraisal of "chronic Lyme disease". N Engl J Med (2007) 7.84

Lyme borreliosis. Lancet (2011) 4.81

Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48

Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann Intern Med (2003) 3.96

Differentiation of reinfection from relapse in recurrent Lyme disease. N Engl J Med (2012) 3.79

Subjective symptoms after treatment of early Lyme disease. Am J Med (2010) 3.22

Serodiagnosis of Lyme disease by kinetic enzyme-linked immunosorbent assay using recombinant VlsE1 or peptide antigens of Borrelia burgdorferi compared with 2-tiered testing using whole-cell lysates. J Infect Dis (2003) 3.18

Prospective clinical evaluation of patients from Missouri and New York with erythema migrans-like skin lesions. Clin Infect Dis (2005) 3.04

Antiscience and ethical concerns associated with advocacy of Lyme disease. Lancet Infect Dis (2011) 2.88

Common misconceptions about Lyme disease. Am J Med (2013) 2.84

Treatment trials for post-Lyme disease symptoms revisited. Am J Med (2013) 2.75

MLST of housekeeping genes captures geographic population structure and suggests a European origin of Borrelia burgdorferi. Proc Natl Acad Sci U S A (2008) 2.67

Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms. Brain Behav Immun (2010) 2.50

Perishock pause: an independent predictor of survival from out-of-hospital shockable cardiac arrest. Circulation (2011) 2.31

Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J Infect Dis (2008) 2.26

Southern Tick-Associated Rash Illness (STARI) in the North: STARI following a tick bite in Long Island, New York. Clin Infect Dis (2011) 2.19

Human Borrelia miyamotoi infection in the United States. N Engl J Med (2013) 2.11

Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis (2002) 1.97

The propensity of different Borrelia burgdorferi sensu stricto genotypes to cause disseminated infections in humans. Am J Trop Med Hyg (2008) 1.82

Reinfection in patients with Lyme disease. Clin Infect Dis (2007) 1.81

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis. J Antimicrob Chemother (2010) 1.75

Persistent and relapsing babesiosis in immunocompromised patients. Clin Infect Dis (2008) 1.71

Serologic markers of Lyme disease in children with autism. JAMA (2013) 1.67

Empiric antibiotic treatment of erythema migrans-like skin lesions as a function of geography: a clinical and cost effectiveness modeling study. Vector Borne Zoonotic Dis (2013) 1.59

Chlorhexidine bathing to reduce central venous catheter-associated bloodstream infection: impact and sustainability. Am J Med (2012) 1.50

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease. Diagn Microbiol Infect Dis (2012) 1.45

Single-dose prophylaxis against Lyme disease. Lancet Infect Dis (2007) 1.45

Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients. J Clin Microbiol (2002) 1.45

Poly-ticks: Blue State versus Red State for Lyme disease. Lancet (2005) 1.42

Why has Borrelia burgdorferi not been transmitted by blood transfusion? Transfusion (2013) 1.42

Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of erythema migrans lesions: correlation of results with clinical and laboratory findings. J Clin Microbiol (2002) 1.40

Comparative genome hybridization reveals substantial variation among clinical isolates of Borrelia burgdorferi sensu stricto with different pathogenic properties. J Bacteriol (2006) 1.34

Borrelia burgdorferi basic membrane proteins A and B participate in the genesis of Lyme arthritis. J Exp Med (2007) 1.29

Brief communication: hematogenous dissemination in early Lyme disease. Ann Intern Med (2005) 1.24

Babesiosis in Lower Hudson Valley, New York, USA. Emerg Infect Dis (2011) 1.24

Natural history of colonization with vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus, and resistant gram-negative bacilli among long-term-care facility residents. Infect Control Hosp Epidemiol (2003) 1.24

Improving the yield of blood cultures from patients with early Lyme disease. J Clin Microbiol (2011) 1.22

Cutaneous vasculitis: diagnosis and management. Clin Dermatol (2006) 1.20

Bartonella spp. transmission by ticks not established. Emerg Infect Dis (2010) 1.19

Epitope mapping of antibodies to VlsE protein of Borrelia burgdorferi in post-Lyme disease syndrome. Clin Immunol (2011) 1.18

Borrelia burgdorferi sensu stricto is clonal in patients with early Lyme borreliosis. Appl Environ Microbiol (2008) 1.16

2-tiered antibody testing for early and late Lyme disease using only an immunoglobulin G blot with the addition of a VlsE band as the second-tier test. Clin Infect Dis (2010) 1.15

Erythema migrans. Infect Dis Clin North Am (2008) 1.14

Borrelia miyamotoi sensu lato seroreactivity and seroprevalence in the northeastern United States. Emerg Infect Dis (2014) 1.13

Seroprevalence of antibodies that react with Anaplasma phagocytophila, the agent of human granulocytic ehrlichiosis, in different populations in Westchester County, New York. J Clin Microbiol (2002) 1.11

A comparison of two treatment regimens of ceftriaxone in late Lyme disease. Wien Klin Wochenschr (2005) 1.10

Comparison of five diagnostic modalities for direct detection of Borrelia burgdorferi in patients with early Lyme disease. Diagn Microbiol Infect Dis (2012) 1.10

Microbiologic evaluation of patients from Missouri with erythema migrans. Clin Infect Dis (2005) 1.10

Anti-Borrelia burgdorferi antibody profile in post-Lyme disease syndrome. Clin Vaccine Immunol (2011) 1.09

Impact of clinical variables on Borrelia burgdorferi-specific antibody seropositivity in acute-phase sera from patients in North America with culture-confirmed early Lyme disease. Clin Vaccine Immunol (2008) 1.08

Variations in Barbour-Stoenner-Kelly culture medium modulate infectivity and pathogenicity of Borrelia burgdorferi clinical isolates. Infect Immun (2004) 1.08

MonoMAC syndrome in a patient with a GATA2 mutation: case report and review of the literature. Clin Infect Dis (2013) 1.08

Multilocus sequence typing of Borrelia burgdorferi suggests existence of lineages with differential pathogenic properties in humans. PLoS One (2013) 1.07

Recombinant assay for serodiagnosis of Lyme disease regardless of OspA vaccination status. J Clin Microbiol (2002) 1.02

Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One (2011) 1.00

A decline in C6 antibody titer occurs in successfully treated patients with culture-confirmed early localized or early disseminated Lyme Borreliosis. Clin Diagn Lab Immunol (2005) 0.99

Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity. Clin Infect Dis (2012) 0.98

Erythromycin resistance in Borrelia burgdorferi. Antimicrob Agents Chemother (2002) 0.98

The amber theory of Lyme arthritis: initial description and clinical implications. Clin Rheumatol (2012) 0.97

Blood cultures for patients with extracutaneous manifestations of Lyme disease in the United States. Clin Infect Dis (2009) 0.94

Efficacy of short-course ceftriaxone therapy for Borrelia burgdorferi infection in C3H mice. Antimicrob Agents Chemother (2002) 0.94

A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease. Clin Infect Dis (2013) 0.93

Comparison of erythema migrans caused by Borrelia burgdorferi and Borrelia garinii. Vector Borne Zoonotic Dis (2011) 0.92

Oral doxycycline for neuroborreliosis. Lancet Neurol (2008) 0.92

CTX-M β-lactamase-producing Klebsiella pneumoniae in suburban New York City, New York, USA. Emerg Infect Dis (2013) 0.91

Diagnosis and Management of Tickborne Rickettsial Diseases: Rocky Mountain Spotted Fever and Other Spotted Fever Group Rickettsioses, Ehrlichioses, and Anaplasmosis - United States. MMWR Recomm Rep (2016) 0.90

Hepatitis in association with rickettsialpox. Vector Borne Zoonotic Dis (2008) 0.89

Long-Term Assessment of Fibromyalgia in Patients with Culture-Confirmed Lyme Disease. Arthritis Rheumatol (2014) 0.89

Borrelia burgdorferi BmpA, BmpB, and BmpD proteins are expressed in human infection and contribute to P39 immunoblot reactivity in patients with Lyme disease. Clin Diagn Lab Immunol (2005) 0.89

Recognition and treatment of erythema migrans: are we off target? Ann Intern Med (2002) 0.88

Vertical transmission of Babesia microti, United States. Emerg Infect Dis (2012) 0.88